Joanna Maleszka

Associate, Warsaw

Biography

Overview

Joanna Maleszka specializes in public and private M&A transactions. She supports clients in navigating the complexities of corporate transactions, ensuring compliance with legal and regulatory requirements.

Her work encompasses various aspects of M&A, including conducting due diligence and supporting transaction closings. Joanna is skilled in analyzing legal issues and providing strategic insights that help clients achieve their business objectives. She also participates in projects related to corporate governance and incentive programs for public companies.

Bars and Courts
Poland, Master's Degree
Education
LLM
University of Warsaw
Center for American Law Studies
Emory University School of Law and Georgia State University College of Law (coordinated by the University of Warsaw)
Bachelor’s, Global Business, Finance and Management (Governance) Department
Warsaw School of Economics
Languages
Polish
English
German

Experience

Selected transactions:

Europi Property Group: representation of Europi Property Group, a European real estate fund, on a transaction involving the management buyout and delisting of Capital Park S.A. and the subsequent acquisition of certain assets of the Capital Park group by a joint venture of the managers and Europi Property Group.

International Schools Partnership: representation of International Schools Partnership, a leading organization that develops educational opportunities around the world, on the acquisition of Akademeia Educational Group (AEG), the operator of an independent, academically selective school in Warsaw.

KRAFTON Inc.: representation of KRAFTON Inc., a South Korean video game holding company, on its investment agreement with PCF Group, a Polish video games producer listed on the Warsaw Stock Exchange.

PFR (Polish Development Fund): representation of PFR in connection with the exit from its equity and debt investment in a Polish private company.

One of the main foreign issuers on the Polish stock exchange: representation of one of the main foreign issuers on the Polish stock exchange on the issuance and admission to trading of its shares on the Polish stock exchange.

European Investment Bank (EIB): representation of the EIB on financing for Ryvu Therapeutics, a clinical-stage drug discovery and development company focusing on novel small molecule therapies that address emerging targets in oncology.